Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Times cited: 88
Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research.
Times cited: 106
The influence of radiotherapy on cosmetic outcome after breast conservative surgery.
International Journal of Radiation Oncology Biology Physics.
Times cited: 32